Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 4, 2001

View Archived Issues

Cephalon reports changes in Gabitril product name

Physiome Sciences licenses PathwayPrism technology to 3rd Millennium

Samaritan's Anticort completes phase Ib/IIa clinical trial for HIV infection

Study investigates Toprol-XL for reversal of cardiac remodeling

AtheroGenics files IND for intravenous AGIX-4207 to treat RA

Senju to develop ocular formulation of betotastine

Modex reports positive preliminary results from EpiDex phase II clinical trial

Levulan progress reported by Dusa during Q2

Hybrid molecule enhances insulin secretion and reduces insulin resistance

Dose-finding trial results presented this week for new fibrin-specific thrombolytic agent

Improvement in ischemic limb muscle oxygenation reported for 5-HT2A receptor antagonist

Beneficial effects of HMR-1098 in atrial and ventricular fibrillation

Effects of rPSGL-Ig in canine model of myocardial ischemia-reperfusion injury

AIDS therapeutic from Takeda enters clinical testing

Metabasis receives SBIR grant for hepatitis B prodrug development

Structure, pharmacological profile of new bladder-selective K(ATP) channel openers presented at ACS

Histone deacetylase inhibition as a novel therapeutic approach to atherosclerosis and restenosis

AstraZeneca reassesses ZD-0473 phase III clinical program in ovarian cancer

Rational design of antimalarial trioxane with promising preclinical efficacy/toxicity profile

BMS files IND for obesity drug candidate developed with Karo Bio

Feridex I.V. sNDA deemed not approvable by FDA

Pyrazolopyridine adenosine A1 antagonist selected for further development at Fujisawa

Macrolides discovered at Pfizer with antiinfective and prokinetic properties

New compounds with estrogenic or antiestrogenic effects claimed by Pfizer

Antiallergic/antiinflammatory agents from Ube act as leukotriene antagonists

Immunomodulatory peptides identified by Entopharm

Amycomycin: a new antibiotic produced by Amycolatopsis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...